Delivery Order SPE2DE21D7010-SPE2D626F29J7
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,646.10 fixed-price delivery order (Contract #4570184048) on December 2, 2025, for RELINE OPEN IMPLANTS. This delivery order, issued without set-aside designation, is funded through the Defense Logistics Agency Medical Supply Chain and includes an economic price adjustment mechanism to address cost fluctuations. Performance is scheduled for completion by December 3,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $27,850.06 fixed-price delivery order for RELINE-ONE spinal implant products on December 10, 2025, with an ultimate completion date of December 11, 2025. This delivery order, which carries no set-aside designation, was issued by the Defense Logistics Agency Medical Supply Chain to support Department of Defense and Department of Veterans Affairs healthcare facilities. The...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a fixed-price delivery order valued at $12,607.94 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025. This delivery order, with an ultimate completion date of January 5, 2026, covers the procurement of RELINE OPEN IMPLANTS—specialized spinal surgical implants designed to support advanced orthopedic and neurosurgical procedures. The award was...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $31,501.86 delivery order (Contract No. 4570253545) by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 2, 2026. The contract, issued without set-aside designation, is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the RELINE-ONE spinal implant product line....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc. received a $11,751.69 delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025, for RELINE MAS IMPLANTS with an ultimate completion date of January 14, 2026. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and was awarded without set-aside restrictions, reflecting Nuvasive's successful competition in open market federal procurements. Performance will be conducted at Nuvasive's facility in San...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $55,910.77 on December 11, 2025, for reline open implants under contract 4570278357. This fixed-price delivery order with economic price adjustment mechanisms is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F29J7Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a $13,362.36 fixed-price delivery order (Contract No. 4570340917) on December 10, 2025, for the RELINE-C spinal implant system, with performance scheduled for completion by December 11, 2025, at the company's San Diego, California facility. The contract was funded through the Defense Logistics Agency Medical Supply Chain without set-aside designation, reflecting open competition among qualified medical device suppliers. This delivery order is issued against Nuvasive's parent company, Transplant Technology Inc., which maintains an $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity contract vehicle through March 2027. This strategic BPA framework enables rapid procurement and delivery of Nuvasive's comprehensive portfolio of spinal medical devices and surgical instrumentation to Department of Defense and Department of Veterans Affairs healthcare facilities. The RELINE-C delivery order represents the company's continued role as a critical supplier of advanced spinal fusion devices and related biologics to federal military and veteran healthcare systems. The fixed-price with economic price adjustment structure provides budgetary certainty while accommodating cost adjustments in specialized medical device procurement. Nuvasive has demonstrated sustained capability in delivering orthopedic and neurosurgical technologies across multiple federal healthcare agencies, supported by its extensive contract history with the Defense Logistics Agency Medical Supply Chain and supplementary awards from the Defense Health Agency and Veterans Integrated Service Networks. The brief performance timeline reflects the urgent medical supply requirements of the federal healthcare enterprise and the company's operational readiness to support advanced surgical capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 12/9/25 |